Joji Suzuki, MD
Assistant Professor of Psychiatry, Harvard Medical School
Director, Division of Addiction Psychiatry, Department of Psychiatry
Dr. Suzuki is the Director of the Division of Addiction Psychiatry and Director of Addictions Education in the Department of Psychiatry, Brigham and Women’s Hospital, and an Assistant Professor of Psychiatry at Harvard Medical School (HMS). Dr Suzuki is a consultation-liaison psychiatrist in the Division of Medical Psychiatry at Brigham and Women’s Hospital. His research is focused on integrating evidence-based addiction treatment initiated in general medical settings, and has received funding from NIH, Brigham and Women’s Hospital, and Harvard Medical School. He was recently awarded a NIDA K23 Career Development Award to receive mentored training in conducting clinical trials, and to study the impact of recovery coaches on buprenorphine treatment. He currently serves on a variety of committees, workgroups, and taskforces for Partners HealthCare, Brigham and Women’s Hospital, Harvard Medical School, Massachusetts Hospital Association, and the State of Massachusetts to address the opioid epidemic. He has published over 50 peer-reviewed manuscripts and book chapters as first or co-author.
Director, Division of Addiction Psychiatry, Department of Psychiatry
Dr. Suzuki is the Director of the Division of Addiction Psychiatry and Director of Addictions Education in the Department of Psychiatry, Brigham and Women’s Hospital, and an Assistant Professor of Psychiatry at Harvard Medical School (HMS). Dr Suzuki is a consultation-liaison psychiatrist in the Division of Medical Psychiatry at Brigham and Women’s Hospital. His research is focused on integrating evidence-based addiction treatment initiated in general medical settings, and has received funding from NIH, Brigham and Women’s Hospital, and Harvard Medical School. He was recently awarded a NIDA K23 Career Development Award to receive mentored training in conducting clinical trials, and to study the impact of recovery coaches on buprenorphine treatment. He currently serves on a variety of committees, workgroups, and taskforces for Partners HealthCare, Brigham and Women’s Hospital, Harvard Medical School, Massachusetts Hospital Association, and the State of Massachusetts to address the opioid epidemic. He has published over 50 peer-reviewed manuscripts and book chapters as first or co-author.
Financial relationships
There are no financial relationships to disclose.